Marignima Bennett: Grady Health System Earns the Highest Recognition for Excellence in Stroke Care
Marignima Bennett, Neuroscience and Cardiovascular Outreach Manager at Grady Health System, shared on LinkedIn:
”Most people don’t know how hospitals are held accountable for stroke care.
Let me break it down because we all need knowledge to make informed decisions.
The American Heart Association’s Get With The Guidelines – Stroke program sets the national standard. Hospitals are measured against the latest evidence-based protocols, not just once, but consistently, across every patient, and every shift.
Here’s what the top recognition levels actually mean:
Gold Plus — The team has sustained evidence-based stroke care standards over 2 consecutive years.
This a system-wide commitment for excellence every single day !
Elite Plus — Among the top performers in the country on door-to-needle time.
That’s the window between a patient arriving and receiving clot-busting treatment. In Stroke care minutes matter and seconds matter.
Advanced Therapy — The hospital is delivering the most complex, life-saving stroke interventions available. Not every hospital can say that.
Target: Type 2 Diabetes Honor Roll — Stroke patients with diabetes require a higher level of coordinated care.
Why does this matter to you?
Because if you or someone you love has a stroke, knowing where to go can be the difference between recovery and permanent disability.
This year, Grady Health System received all of the above!!
To the entire Grady Neurology and Emergency department teams — this is a reflection of your hard work, dedication, and commitment to excellence.
Thank you for everything you do.
This recognition is well earned and a testament to the impact we make together.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question
-
Oct 20, 2026, 04:04Sadia Kamal: Honored to Receive the Outstanding Abstract Award at the 20th Midwest Platelet Conference
-
Oct 20, 2026, 04:03Yu-Hsuan Chen: One Antibody, Two Diseases from FcRn Biology to Clinical Translation
-
Oct 20, 2026, 03:49Domenico Simone Castiello: Rethinking Prolonged DAPT in Multivessel PCI – Insights from the DAPT-MVD Trial